A significant drop in Hemostemix Inc's stock raises concerns for investors.
Hemostemix Inc (HEM.V) saw its stock price fall by 20.00% during yesterday's trading session, closing at CA$0.06. This decline has left investors questioning the company's stability and future prospects.
Advertisement
Hemostemix Inc
HEM.V
HEM.V
Hemostemix Inc
WealthAwesomeMarket cap
$12.69M
52W high
$0.11
52W low
$0.04
1W change
-7.69%
Beta
0.73
Analyst Price Targets
Based on analyst covering HEM · as of Sep 17, 2026
Wall Street analysts forecast HEM stock price to rise 1500.0% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$0.96
+1500.0% Upside
Current Price
C$0.06
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on HEM's historical volatility
30-Day Vol
109.5%
Annualized
90-Day Vol
118.8%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$0.07
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.06 | C$0.04 – C$0.09 |
| 60 trading days | C$0.07 | C$0.04 – C$0.12 |
| 90 trading days | C$0.07 | C$0.04 – C$0.14 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors should remain cautious as Hemostemix Inc's recent performance raises red flags about its financial health and market confidence.
20.00% Decline in Stock Price
Hemostemix Inc's market cap now stands at CA$12,686,486, reflecting investor concerns over its financial viability.
Bull case
Despite the recent downturn, Hemostemix is actively securing funding through private placements. This could provide the necessary capital for growth and help the company stabilize.
Bear case
The 20.00% drop in stock price signals a loss of investor confidence, likely due to ongoing financial struggles and a lack of recent positive news.
Advertisement
Market Reaction and Investor Sentiment
The 20.00% drop in Hemostemix Inc's stock price yesterday indicates a significant shift in market sentiment. Investors may be reacting to the company's ongoing financial challenges and the absence of recent positive developments. With a market cap of approximately CA$12.7 million, the decline suggests that confidence in the company's future is waning.
Recent Developments and Future Outlook
Despite the downturn, Hemostemix is pursuing funding through private placements. However, the lack of substantial news or positive developments may have contributed to the stock's decline. Investors should watch for future announcements regarding the company's financial strategies and operational progress, as these could influence market perception.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
